Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes

N Engl J Med. 2021 Apr 1;384(13):1248-1260. doi: 10.1056/NEJMcp2000280.
No abstract available

Publication types

  • Review

MeSH terms

  • Blood Glucose
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Heart Disease Risk Factors
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / therapeutic use
  • Metformin / therapeutic use
  • Middle Aged
  • Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin
  • Sodium-Glucose Transporter 2 Inhibitors
  • Metformin
  • Glucagon-Like Peptide-1 Receptor Agonists